| Name | The Ritz |
|---|---|
| Organization Name | Kahle Stores Inc |
| Location | 825 W Market St, Ste 204, Lima, Ohio 45805 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (419) 224-6100 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
University of Otago scientists have opened the door to improved treatment of brain dysfunction which causes psychosis.
Atherosclerosis is the progressive narrowing and hardening of the arteries over time, known to occur to some degree with aging; but other risk factors (such as high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease) that accelerate this process have been identified.
"It is high time to demystify COPD in order to better explain the issues and help people who suffer from this disease," says Dr. Jean Bourbeau, Director of the Respiratory, Epidemiology and Clinical Research Unit at the Montreal Chest Institute of the MUHC, and lead investigator of CanCOLD along with Dr. Wan Tan of The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
› Verified 4 days ago
| NPI Number | 1033118641 |
| Organization Name | SCHMIDT, INC. |
| Doing Business As | THE RITZ...INTIMATELY YOURS |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 825 W Market St, Suite204, Lima, OH 45805 |
| Phone Number | 419-224-6100 |
News Archive
University of Otago scientists have opened the door to improved treatment of brain dysfunction which causes psychosis.
Atherosclerosis is the progressive narrowing and hardening of the arteries over time, known to occur to some degree with aging; but other risk factors (such as high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease) that accelerate this process have been identified.
"It is high time to demystify COPD in order to better explain the issues and help people who suffer from this disease," says Dr. Jean Bourbeau, Director of the Respiratory, Epidemiology and Clinical Research Unit at the Montreal Chest Institute of the MUHC, and lead investigator of CanCOLD along with Dr. Wan Tan of The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
› Verified 4 days ago
| NPI Number | 1245608983 |
| Organization Name | KAHLE STORES, INC. |
| Doing Business As | THE RITZ |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 825 W Market St, Suite 204, Lima, OH 45805 |
| Phone Number | 419-224-6100 |
News Archive
University of Otago scientists have opened the door to improved treatment of brain dysfunction which causes psychosis.
Atherosclerosis is the progressive narrowing and hardening of the arteries over time, known to occur to some degree with aging; but other risk factors (such as high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease) that accelerate this process have been identified.
"It is high time to demystify COPD in order to better explain the issues and help people who suffer from this disease," says Dr. Jean Bourbeau, Director of the Respiratory, Epidemiology and Clinical Research Unit at the Montreal Chest Institute of the MUHC, and lead investigator of CanCOLD along with Dr. Wan Tan of The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
› Verified 4 days ago
News Archive
University of Otago scientists have opened the door to improved treatment of brain dysfunction which causes psychosis.
Atherosclerosis is the progressive narrowing and hardening of the arteries over time, known to occur to some degree with aging; but other risk factors (such as high cholesterol, high blood pressure, smoking, diabetes and family history for atherosclerotic disease) that accelerate this process have been identified.
"It is high time to demystify COPD in order to better explain the issues and help people who suffer from this disease," says Dr. Jean Bourbeau, Director of the Respiratory, Epidemiology and Clinical Research Unit at the Montreal Chest Institute of the MUHC, and lead investigator of CanCOLD along with Dr. Wan Tan of The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia.
RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.
› Verified 4 days ago
Adaptive Medical Marketing Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1378 Bellefontaine Ave, Lima, Ohio 45804 Phone: (419) 224-5410 | |
Bob Johns Shoes Pedorthics & Repair Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2110 Spencerville Rd, Lima, Ohio 45805 Phone: (419) 227-2829 | |
Dasco Home Medical Equipment Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1054 Bellefontaine Ave, Lima, Ohio 45804 Phone: (419) 224-1135 | |
Hanger Prosthetics & Orthotics Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1054 Bellefontaine Ave, Lima, Ohio 45804 Phone: (419) 229-9267 | |
Eye Site Of Lima Type: Medicare Supplier Location: 1034 W Market St, Lima, Ohio 45805 Phone: (419) 228-8116 |